Found: 12
Select item for more details and to access through your institution.
Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 12, p. 1, doi. 10.3389/fonc.2022.1061789
- By:
- Publication type:
- Article
Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1120207
- By:
- Publication type:
- Article
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 649, p. 1, doi. 10.1126/scitranslmed.aba4380
- By:
- Publication type:
- Article
MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 646, p. 1, doi. 10.1126/scitranslmed.abj2829
- By:
- Publication type:
- Article
Correction to: Strategies for Predicting Response to Checkpoint Inhibitors.
- Published in:
- Current Hematologic Malignancy Reports, 2019, v. 14, n. 1, p. 62, doi. 10.1007/s11899-018-0488-0
- By:
- Publication type:
- Article
Strategies for Predicting Response to Checkpoint Inhibitors.
- Published in:
- Current Hematologic Malignancy Reports, 2018, v. 13, n. 5, p. 383, doi. 10.1007/s11899-018-0471-9
- By:
- Publication type:
- Article
APR-246 increases tumor antigenicity independent of p53.
- Published in:
- Life Science Alliance, 2024, v. 7, n. 1, p. 1, doi. 10.26508/lsa.202301999
- By:
- Publication type:
- Article
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17750-z
- By:
- Publication type:
- Article
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.
- Published in:
- 2018
- By:
- Publication type:
- letter
Lymphoma immunotherapy: current status.
- Published in:
- Frontiers in Immunology, 2015, p. 1, doi. 10.3389/fimmu.2015.00448
- By:
- Publication type:
- Article
In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 9, p. 2034, doi. 10.1002/ijc.28852
- By:
- Publication type:
- Article